share_log

Verve Therapeutics | 8-K: Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results

SEC ·  Nov 5 20:16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more